Egis shareholders approve bigger dividend
Shareholders of Hungarian drugmaker Egis, majority-owned by France's Sevier, approved a proposal to pay a HUF 240-per-share dividend on profit from the business year ended September 30 at an annual general meeting on Wednesday. The dividend is double the HUF 120-per-share dividend that Egis has paid for years. CFO Csaba Poroszlai said the dividend was 10% of consolidated net profit. Shareholders approved Egis's Hungarian Accounting Standards P+L statement showing after-tax profit of HUF 20.4 billion on revenue of HUF 131.2 billion.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.